Search

Your search keyword '"Villinger, Francois"' showing total 882 results

Search Constraints

Start Over You searched for: Author "Villinger, Francois" Remove constraint Author: "Villinger, Francois"
882 results on '"Villinger, Francois"'

Search Results

1. Publisher Correction: TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo

2. Epigenetic MLH1 silencing concurs with mismatch repair deficiency in sporadic, naturally occurring colorectal cancer in rhesus macaques

3. TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo

5. Dynamic Analysis of major elements in biological tissue validating quantification of trace life elements in MeV ion beam microscopy

6. Author Correction: A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

7. A ferritin-based COVID-19 nanoparticle vaccine that elicits robust, durable, broad-spectrum neutralizing antisera in non-human primates

9. Tuberculosis detection in nonhuman primates is enhanced by use of testing algorithms that include an interferon-γ release assay.

10. Species-agnostic polymeric formulations for inhalable messenger RNA delivery to the lung

13. Select gp120 V2 domain specific antibodies derived from HIV and SIV infection and vaccination inhibit gp120 binding to α4β7.

16. Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines

17. Simian Immunodeficiency Virus Targeting of CXCR3+ CD4+ T Cells in Secondary Lymphoid Organs Is Associated with Robust CXCL10 Expression in Monocyte/Macrophage Subsets

18. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

19. PLGA-Chitosan Encapsulated IL-10 Nanoparticles Modulate Chlamydia Inflammation in Mice

22. Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells

23. Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques

24. Blockade of TGF-β signaling reactivates HIV-1/SIV reservoirs and immune responses in vivo

25. Germline-targeting SOSIP trimer immunization elicits precursor CD4 binding-site targeting broadly neutralizing antibodies in infant macaques.

28. 8th IAS Conference on HIV Pathogenesis, Treatment & Prevention 19–22 July 2015, Vancouver, Canada

29. Defense-in-depth by mucosally administered anti-HIV dimeric IgA2 and systemic IgG1 mAbs: Complete protection of rhesus monkeys from mucosal SHIV challenge

30. 8th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2015).

31. Multimodality vaccination against clade C SHIV: Partial protection against mucosal challenges with a heterologous tier 2 virus

33. Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose

34. Intranasal parainfluenza virus type 5 (PIV5)–vectored RSV vaccine is safe and immunogenic in healthy adults in a phase 1 clinical study

35. IL‐21‐IgFc immunotherapy alters transcriptional landscape of lymph node cells leading to enhanced flu vaccine response in aging and SIV infection

36. TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirsin vivo

37. Cigarette smoke and HIV synergistically affect lung pathology in cynomolgus macaques

40. Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine

41. Control of a Mucosal Challenge and Prevention of AIDS by a Multiprotein DNA/MVA Vaccine

47. Intranasal vaccination with lipid-conjugated immunogens promotes antigen transmucosal uptake to drive mucosal and systemic immunity

48. Sustained virologic control in SIV⁺ macaques after antiretroviral and α₄β₇ antibody therapy

50. Extremely potent pan-sarbecovirus neutralizing antibodies generated by immunization of macaques with an AS03-adjuvanted monovalent subunit vaccine against SARS-CoV-2

Catalog

Books, media, physical & digital resources